During the past decade, Southern Star Research Institute, LLC conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 10 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 10 clinical trials were completed. i.e. 52.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Star Research Institute, LLC" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Shire" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Phathom Pharmaceuticals, Inc." with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Star Research Institute, LLC" #1 collaborator was "Cristcot HCA LLC" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southern Star Research Institute, LLC" are "Ulcerative Colitis" (10 trials), "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (3 trials), "Crohn Disease" (2 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Southern Star Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "Southern Star Research Institute, LLC" are "Drug" (27 trials), "Other" (6 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Mirikizumab" (4 trials), "Ontamalimab" (4 trials), "Vonoprazan" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southern Star Research Institute, LLC" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Southern Star Research Institute, LLC". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Southern Star Research Institute, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Star Research Institute, LLC, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".